1-3 of 3
Eyck von der Heyde
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 5 th Interim Analysis of the Study RISA, with Special Consideration of Treatment Discontinuations

Oliver Meyer, Rudolf Schlag, Thomas Stauch, Bastian Fleischmann, Marcel Reiser, Dietrich Kaempfe, Timo Behlendorf, Manfred Welslau, Eyck von der Heyde, Steffen Dörfel, Claudia Willy, Martina Stauch
Journal: Blood
Blood (2022) 140 (Supplement 1): 2683–2684.
https://doi.org/10.1182/blood-2022-166741
Published: 2022
Journal Articles

Characteristics of High-Risk Polycythemia Vera Patients with Suboptimal Response to First-Line Therapy Who Switched to Ruxolitinib Vs Those Who Did Not Switch: Findings from PV-Switch, a Multinational, Retrospective Chart Review Study

Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard, Timothy Devos, Francesco Passamonti, Mike W. Zuurman, Carole Paley, Geralyn Gilotti, Wendy Y. Cheng, Chi Gao, Mu Cheng, Melody Wu, Mei Sheng Duh, Claire N. Harrison
Journal: Blood
Blood (2021) 138 (Supplement 1): 3646.
https://doi.org/10.1182/blood-2021-148254
Published: 2021
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 3 rd Interim Analysis of the German Non-Interventional Trial RISA

Oliver Meyer, MD PhD, Martina Stauch, Dietrich Kaempfe, MD, Rudolf Schlag, Marcel Reiser, Eyck von der Heyde, Andreas Josting, Margarete Plath, Nadine Ballerstädt, Petra Stark-Lorenzen, Axel Matzdorff, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-134542
Published: 2020